Safety of videoconferencing for physical rehabilitation and exercise: A systematic review and meta-analysis
Clinical Rehabilitation · 2025-09 · 39 (9) · 1219-1242
DOI: 10.1177/02692155251361916 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Rehabilitation, online erschienen am 30.07.2025. Verfasst von Riley Cc Brown und 5 weiteren Autor:innen. Beteiligte Einrichtung: RECOVER Injury Research Centre, The University of Queensland, Brisbane, Australia. Hauptthemen laut MEDLINE: Videoconferencing, Exercise Therapy, Physical Therapy Modalities, Patient Safety. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Investigate the safety of physical rehabilitation and/or exercise interventions conducted via videoconferencing.
Design
Systematic review/meta-analysis. Data sources PubMed, Web of Science, Embase and CINAHL from inception until 12 June 2025. Review methods Trials including participants with chronic disease or history of restorative or reconstructive surgery implementing a physical rehabilitation or exercise intervention via videoconferencing compared to an in-person exercise comparator and reporting adverse events were included. Meta-analyses were conducted for between-group comparisons of adverse events using incidence rate ratios. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool and the certainty of the evidence with Grading of Recommendations, Assessment, Development and Evaluation.
Results
Out of 3436 records, 22 trials were included in this review (28 otherwise eligible trials were excluded for not reporting adverse events). No significant differences were observed between groups for minor/moderate [incidence rate ratio (IRR): 1.00, 95% CI: 0.71–1.41, p = 1.00] or major (IRR: 1.77, 95% CI: 0.55–5.70, p = 0.98) adverse events. Incidence was low for both videoconferencing (one every 410 sessions) and in-person (one every 414 sessions). Eighteen trials (82%) were graded ‘some concerns’ or ‘high’ on overall risk of bias score, primarily due to bias arising from measurement and selection of the reported adverse events. Certainty grading was ‘low’ for adverse event outcomes.
Conclusion
This study suggests that there is no clear evidence of a difference in adverse event incidence between in-person and videoconferencing physical rehabilitation or exercise interventions. Future studies must improve transparency of defining and reporting to improve certainty in these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- RECOVER Injury Research Centre, The University of Queensland, Brisbane, Australia.
- STARS Education and Research Alliance, Surgical Treatment and Rehabilitation Service, The University of Queensland and Metro North Health, Brisbane, Australia.
- Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain.
ORCID-Profile: Riley Cc Brown, Joshua Simmich, Robert Cuthbert, Megan H Ross, Pablo Molina-Garcia, Trevor G Russell
Zitieren
APA
Brown, R. C., Simmich, J., Cuthbert, R., Ross, M. H., Molina-Garcia, P., & Russell, T. G. (2025). Safety of videoconferencing for physical rehabilitation and exercise: A systematic review and meta-analysis. Clinical Rehabilitation, 39(9), 1219-1242. https://doi.org/10.1177/02692155251361916
Vancouver
Brown RC, Simmich J, Cuthbert R, Ross MH, Molina-Garcia P, Russell TG. Safety of videoconferencing for physical rehabilitation and exercise: A systematic review and meta-analysis. Clinical Rehabilitation. 2025;39(9):1219-1242. doi:10.1177/02692155251361916
BibTeX
@article{Brown2025,
author = {Brown, Riley Cc and Simmich, Joshua and Cuthbert, Robert and Ross, Megan H and Molina-Garcia, Pablo and Russell, Trevor G},
title = {Safety of videoconferencing for physical rehabilitation and exercise: A systematic review and meta-analysis},
journal = {Clinical Rehabilitation},
year = {2025},
volume = {39},
number = {9},
pages = {1219--1242},
doi = {10.1177/02692155251361916}
}
EUVIMED